CH582695A5 - - Google Patents

Info

Publication number
CH582695A5
CH582695A5 CH738274A CH738274A CH582695A5 CH 582695 A5 CH582695 A5 CH 582695A5 CH 738274 A CH738274 A CH 738274A CH 738274 A CH738274 A CH 738274A CH 582695 A5 CH582695 A5 CH 582695A5
Authority
CH
Switzerland
Application number
CH738274A
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of CH582695A5 publication Critical patent/CH582695A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
CH738274A 1973-05-30 1974-05-30 CH582695A5 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5970973A JPS535678B2 (zh) 1973-05-30 1973-05-30

Publications (1)

Publication Number Publication Date
CH582695A5 true CH582695A5 (zh) 1976-12-15

Family

ID=13120999

Family Applications (1)

Application Number Title Priority Date Filing Date
CH738274A CH582695A5 (zh) 1973-05-30 1974-05-30

Country Status (6)

Country Link
JP (1) JPS535678B2 (zh)
CH (1) CH582695A5 (zh)
DE (1) DE2426304A1 (zh)
FR (1) FR2231388B1 (zh)
GB (1) GB1449708A (zh)
HU (1) HU170244B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2614946A1 (de) * 1975-04-08 1976-10-14 Asahi Chemical Ind Neue nucleotidderivate
JPS51143683A (en) * 1975-06-06 1976-12-10 Yamasa Shoyu Co Ltd A process for preparing n4- acylarabinofuranosyl cytosines
JPS5840528B2 (ja) * 1975-12-31 1983-09-06 旭化成株式会社 Ｎ４− ベヘノイルシトシンアラビノシドノスイヨウカホウホウ
JPS552602A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester
JPS5622724A (en) * 1979-08-02 1981-03-03 Asahi Chem Ind Co Ltd Pharmaceutical preparation of n4-acylcytosine arabinoside
DE3323621A1 (de) * 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
JPS5925327A (ja) * 1982-07-31 1984-02-09 Hidematsu Hirai 抗腫瘍性複合体の製造方法
JPS6330879Y2 (zh) * 1985-08-30 1988-08-17
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
CN102325783A (zh) 2008-12-23 2012-01-18 法莫赛特股份有限公司 嘌呤核苷的合成
WO2010075549A2 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside phosphoramidates
SI3290428T1 (sl) 2010-03-31 2022-01-31 Gilead Pharmasset Llc Tableta, ki obsega kristalinični (S)-izopropil 2-(((S)-(((2R,3R,4R,5R) -5-(2,4-diokso-3,4-dihidropirimidin-1(2H)-il)-4-fluoro-3-hidroksi-4- metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
EP3453386A1 (en) * 2017-09-08 2019-03-13 Universite D'angers Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
CN108409819A (zh) * 2018-04-25 2018-08-17 山东大学 一种新型阿糖胞苷前药DA-Ara纳米组装体的制备方法及应用
CN108727449A (zh) * 2018-04-25 2018-11-02 山东大学 一种新型阿糖胞苷前药MA-Ara纳米组装体的制备方法及应用
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法

Also Published As

Publication number Publication date
FR2231388B1 (zh) 1977-11-04
HU170244B (zh) 1977-05-28
GB1449708A (en) 1976-09-15
JPS5018482A (zh) 1975-02-26
JPS535678B2 (zh) 1978-03-01
FR2231388A1 (zh) 1974-12-27
DE2426304C2 (zh) 1988-03-17
DE2426304A1 (de) 1975-01-02

Similar Documents

Publication Publication Date Title
AR201758A1 (zh)
AR201235Q (zh)
AR201231Q (zh)
AU474593B2 (zh)
AU474511B2 (zh)
AU474838B2 (zh)
FR2231388B1 (zh)
AU465453B2 (zh)
AU465434B2 (zh)
AU471343B2 (zh)
AU476714B2 (zh)
AR201229Q (zh)
AU472848B2 (zh)
AU476696B2 (zh)
AR199451A1 (zh)
AR201432A1 (zh)
AR197627A1 (zh)
AR195311A1 (zh)
AR200256A1 (zh)
AR195948A1 (zh)
AU471461B2 (zh)
AR200885A1 (zh)
AR196382A1 (zh)
AR210729A1 (zh)
AR196123Q (zh)

Legal Events

Date Code Title Description
PL Patent ceased